Vital Farms, Inc. (VITL) · Nov 3, 2026 · Earnings

Vital Farms earnings beat revenue, but guidance and 2030 targets collapse

Miss — FY revenue ~$730M vs $775M-$800M prior outlook; EBITDA loss ~$15M vs $0M-$10M gain

Vital Farms’ Q3 earnings showed sequential recovery, but sharply lower 2026 guidance, cash burn and withdrawn 2030 targets reset the story.

Vital Farms is a national pasture-raised egg brand that spent 2025 building supply-chain capacity and entered 2026 trying to convert that capacity into distribution and household growth. That expansion story has collided with a normalized egg market, excess supply and weaker pricing; the company is now shifting from growth investment toward supply control, cost reduction and proving profitability.

The quarter improved sequentially, but it did not repair the underlying earnings damage. Revenue was slightly above one published consensus estimate, while diluted EPS was worse than expected; more importantly, gross margin fell to 23.1% from 37.7% as oversupply pushed product into lower-priced breaker and wholesale channels. The filing says that unfavorable mix reduced gross profit by $7.9 million. 〔0〕

MetricQ3 2026Q3 2025Consensus / prior guide
Net revenue (Financial Highlights)$182.2M (+9.7% sequentially)$198.9M~$181.8M consensus
Diluted EPS (Financial Highlights)$(0.15)$0.36~$(0.11) consensus
Gross margin (Financial Highlights)23.1%37.7%
Adjusted EBITDA (Adjusted EBITDA Reconciliation)$1.5M$27.4M
FY2026 net revenue outlook (Fiscal 2026 Outlook)~$730M$775M-$800M prior outlook
FY2026 adjusted EBITDA outlook (Fiscal 2026 Outlook)~$(15)M$0M-$10M prior outlook

The real reset is in the outlook, not the quarter. Vital Farms cut full-year revenue guidance by roughly 7% from the midpoint of its prior range and moved from expecting at least break-even adjusted EBITDA to forecasting a $15 million loss. Management attributes the change to distribution arriving later than planned, weaker near-term velocity and no assumed seasonal lift in demand or conventional egg pricing. 〔1〕

Withdrawing the 2030 targets removes the long-term proof point that supported the expansion plan. The company had previously framed 2026 as a market-expansion year on a path toward $2 billion of revenue by 2030; it now says it will revisit those targets only after making more progress on margins and profitability. That is a material change in the business story, not merely a quarterly miss. 〔2〕

The balance sheet provides runway, but the turnaround is consuming it. Vital Farms ended the quarter with $84.0 million of cash against $117.6 million of debt and used $54.4 million in operating cash during the first 39 weeks, while still planning $70 million-$75 million of 2026 capital spending.

Bottom line: Q3 showed the expected sequential recovery, but the sharply lower outlook and withdrawal of the 2030 targets overturn the prior growth-and-margin-expansion narrative. Vital Farms is now proving whether distribution gains can translate into profitable velocity before cash and credibility become tighter constraints.

What to watch next

Q4 results and FY2027 outlook

Original filing on SEC EDGAR

More Vital Farms, Inc. news

Vital Farms earnings beat revenue, but guidance and 2030 targets collapse | VITL Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.